Nifty

:

23907.25

Sensex

:

79117.11

557.35 (2.39%)
1961.32 (2.54%)

Login

Nifty
Sensex

:
:

23907.25
79117.11

557.35 (2.39%)
1961.32 (2.54%)

Fredun Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 539730 | NSE: Not Listed

Watchlist

NSE BSE

673.7

22-Nov-2024

Open
High
Low
Previous Close

675
697.9
655
672.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

8573
5835764
1054.00
650.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

327.16
18.50
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

463.86
0.10%
2.50

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

29.96
25.29
15.76

EBITDA CAGR (%)

10 Years
5 Years
3 Years

36.76
35.46
22.26

PAT CAGR (%)

10 Years
5 Years
3 Years

50.62
52.40
35.06

P:E (Median)

8 Years
5 Years
3 Years

43.37
45.66
39.04

P:BV (Average)

8 Years
5 Years
3 Years

4.11
4.11
4.69

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.44
18.48
20.99

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 107.35 81.98 30.95% 78.81 62.05 27.01% 118.03 79.80 47.91% 87.01 77.96 11.61%
Expenses 93.40 72.38 29.04% 68.33 54.44 25.51% 106.87 67.54 58.23% 76.49 70.65 8.27%
EBITDA 13.95 9.61 45.16% 10.48 7.61 37.71% 11.17 12.26 -8.89% 10.52 7.31 43.91%
EBIDTM 13.00% 11.72% 13.30% 12.26% 9.46% 15.36% 12.09% 9.37%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 5.31 2.90 83.10% 3.91 2.61 49.81% 4.37 3.55 23.10% 3.77 1.95 93.33%
Depreciation 1.06 0.94 12.77% 1.05 0.92 14.13% 0.96 0.70 37.14% 0.99 0.74 33.78%
PBT 7.58 5.77 31.37% 5.52 4.08 35.29% 5.84 8.01 -27.09% 5.76 4.62 24.68%
Tax 3.30 1.83 80.33% 1.39 1.68 -17.26% 0.78 4.12 -81.07% 1.54 1.16 32.76%
PAT 4.27 3.94 8.38% 4.13 2.40 72.08% 5.06 3.89 30.08% 4.22 3.46 21.97%
PATM 3.98% 4.80% 5.24% 3.87% 4.29% 4.88% 4.85% 4.43%
EPS 9.09 8.38 8.47% 8.79 5.11 72.02% 10.77 8.28 30.07% 8.98 7.36 22.01%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 391.20 348.16 274.68 224.46 133.89 112.77 97.02 59.55 56.70 42.32 25.33 Net Sales Growth 29.63% 26.75% 22.37% 67.65% 18.73% 16.23% 62.92% 5.03% 33.98% 67.07% Cost Of Goods Sold 286.75 261.32 208.68 177.10 102.25 81.75 59.88 39.51 24.57 19.04 15.31 Gross Profit 104.45 86.83 65.99 47.35 31.65 31.02 37.14 20.04 32.12 23.29 10.02 GP Margin 26.70% 24.94% 24.02% 21.10% 23.64% 27.51% 38.28% 33.65% 56.65% 55.03% 39.56% Total Expenditure 345.09 310.17 246.90 210.55 124.55 104.44 86.99 53.84 53.37 38.42 23.67 Power & Fuel Cost - 4.47 3.37 3.49 2.94 3.10 2.75 1.60 1.64 1.17 0.84 % Of Sales - 1.28% 1.23% 1.55% 2.20% 2.75% 2.83% 2.69% 2.89% 2.76% 3.32% Employee Cost - 12.50 11.54 10.66 8.66 8.95 8.04 5.19 4.92 3.83 3.22 % Of Sales - 3.59% 4.20% 4.75% 6.47% 7.94% 8.29% 8.72% 8.68% 9.05% 12.71% Manufacturing Exp. - 10.34 7.24 4.41 3.13 3.58 4.03 1.21 15.32 9.47 0.70 % Of Sales - 2.97% 2.64% 1.96% 2.34% 3.17% 4.15% 2.03% 27.02% 22.38% 2.76% General & Admin Exp. - 15.85 10.81 8.72 5.47 5.19 7.13 3.57 3.34 1.93 1.72 % Of Sales - 4.55% 3.94% 3.88% 4.09% 4.60% 7.35% 5.99% 5.89% 4.56% 6.79% Selling & Distn. Exp. - 5.07 4.24 5.61 1.77 1.76 2.59 2.54 3.46 2.71 1.64 % Of Sales - 1.46% 1.54% 2.50% 1.32% 1.56% 2.67% 4.27% 6.10% 6.40% 6.47% Miscellaneous Exp. - 0.62 1.00 0.56 0.33 0.11 2.57 0.21 0.11 0.27 1.64 % Of Sales - 0.18% 0.36% 0.25% 0.25% 0.10% 2.65% 0.35% 0.19% 0.64% 0.95% EBITDA 46.12 37.99 27.78 13.91 9.34 8.33 10.03 5.71 3.33 3.90 1.66 EBITDA Margin 11.79% 10.91% 10.11% 6.20% 6.98% 7.39% 10.34% 9.59% 5.87% 9.22% 6.55% Other Income 0.00 0.92 1.82 1.63 1.40 0.52 0.58 0.16 1.91 0.86 0.49 Interest 17.36 13.65 9.28 4.78 4.37 4.47 3.12 1.95 1.87 2.06 1.05 Depreciation 4.06 3.80 2.81 2.16 2.00 1.88 1.33 1.29 1.14 0.80 0.55 PBT 24.70 21.45 17.51 8.60 4.37 2.49 6.16 2.64 2.23 1.90 0.55 Tax 7.01 5.83 6.70 2.26 1.19 0.59 1.70 0.89 0.80 0.77 0.26 Tax Rate 28.38% 27.18% 38.26% 26.28% 37.07% 23.69% 27.60% 33.71% 35.87% 41.85% 50.00% PAT 17.68 15.62 10.81 6.34 2.01 1.90 4.46 1.75 1.43 1.07 0.26 PAT before Minority Interest 17.68 15.62 10.81 6.34 2.01 1.90 4.46 1.75 1.43 1.07 0.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.52% 4.49% 3.94% 2.82% 1.50% 1.68% 4.60% 2.94% 2.52% 2.53% 1.03% PAT Growth 29.15% 44.50% 70.50% 215.42% 5.79% -57.40% 154.86% 22.38% 33.64% 311.54% EPS 37.62 33.23 23.00 13.49 4.28 4.04 9.49 3.72 3.04 2.28 0.55

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 121.47 96.38 68.06 43.07 41.32 38.99 22.16 7.26 3.96 3.08 Share Capital 4.70 4.53 4.43 3.99 3.99 3.99 3.43 4.87 2.62 2.62 Total Reserves 115.20 83.52 63.42 39.08 37.33 35.00 18.74 2.39 1.34 0.46 Non-Current Liabilities 19.30 21.25 45.18 32.09 14.07 12.51 4.06 8.37 7.31 3.69 Secured Loans 12.80 15.44 42.04 29.11 11.50 10.64 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.24 6.19 2.94 Long Term Provisions 2.37 1.96 1.71 1.60 1.63 1.08 3.25 0.28 0.43 0.21 Current Liabilities 166.83 139.66 73.75 86.46 85.99 53.41 53.04 40.47 31.93 16.22 Trade Payables 62.95 59.34 48.62 59.96 46.22 33.70 38.92 22.83 16.27 6.99 Other Current Liabilities 11.59 8.31 11.62 14.84 13.79 8.94 1.33 7.75 7.18 2.82 Short Term Borrowings 86.76 67.71 10.72 10.53 23.41 8.63 9.90 7.58 6.85 5.10 Short Term Provisions 5.54 4.29 2.79 1.13 2.57 2.13 2.89 2.31 1.62 1.31 Total Liabilities 307.60 257.29 186.99 161.62 141.38 104.91 79.26 56.10 43.20 22.99 Net Block 46.57 38.93 32.34 30.35 30.97 31.35 16.28 20.50 14.51 7.92 Gross Block 62.98 51.54 42.14 37.99 36.61 35.11 25.00 27.93 20.80 13.40 Accumulated Depreciation 16.40 12.61 9.80 7.64 5.64 3.76 8.71 7.43 6.29 5.49 Non Current Assets 50.40 41.07 34.34 31.54 32.05 32.39 27.78 20.85 14.92 9.81 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 11.15 0.00 0.00 1.41 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 3.36 2.13 2.00 1.18 1.08 1.03 0.35 0.35 0.31 0.48 Other Non Current Assets 0.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.00 Current Assets 257.20 216.21 152.65 130.08 109.32 72.52 51.48 35.24 28.28 13.08 Current Investments 0.81 0.31 0.06 0.06 0.05 0.00 0.00 0.00 0.00 0.00 Inventories 175.00 150.12 46.46 67.57 50.46 40.78 18.43 6.94 10.27 4.29 Sundry Debtors 64.85 34.56 90.27 41.08 38.97 17.78 15.26 20.38 11.40 5.19 Cash & Bank 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 0.60 Other Current Assets 15.20 0.75 0.58 0.36 16.78 12.49 16.35 7.18 5.22 3.00 Short Term Loans & Adv. 13.76 27.03 13.20 19.89 16.49 0.75 7.70 6.31 5.01 1.05 Net Current Assets 90.37 76.55 78.90 43.63 23.33 19.11 -1.56 -5.23 -3.65 -3.14 Total Assets 307.60 257.28 186.99 161.62 141.37 104.91 79.26 56.09 43.20 23.00

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -0.44 -14.41 -2.38 0.17 -10.64 0.84 17.30 3.97 3.33 1.78 PBT 21.45 17.46 8.58 2.01 2.35 6.18 1.75 2.23 1.83 0.52 Adjustment 16.77 11.70 7.82 8.65 6.03 2.08 2.67 2.00 1.74 1.15 Changes in Working Capital -38.66 -43.57 -18.77 -10.50 -19.02 -7.43 12.88 -0.25 -0.25 0.11 Cash after chg. in Working capital -0.44 -14.41 -2.38 0.17 -10.64 0.84 17.30 3.97 3.33 1.78 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.64 -9.40 -4.14 -1.39 -1.49 -5.25 -8.21 -7.13 -5.99 -3.00 Net Fixed Assets -11.44 -9.40 -4.15 -1.38 -1.50 1.04 -8.22 -7.13 -5.99 -2.71 Net Investments -0.50 -0.25 0.00 -0.01 -0.05 0.00 0.00 0.00 0.00 0.00 Others 4.30 0.25 0.01 0.00 0.06 -6.29 0.01 0.00 0.00 -0.29 Cash from Financing Activity 5.99 25.18 7.47 -0.71 13.73 4.43 -8.38 2.52 3.45 1.40 Net Cash Inflow / Outflow -2.08 1.36 0.94 -1.93 1.59 0.01 0.70 -0.64 0.79 0.18 Opening Cash & Equivalents 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 0.60 0.42 Closing Cash & Equivalent 1.35 3.44 2.07 1.13 3.06 1.47 1.45 0.75 1.39 0.60

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 255.15 194.27 153.07 107.96 103.57 97.73 64.71 20.14 15.68 11.50 ROA 5.53% 4.86% 3.63% 1.33% 1.54% 4.84% 2.59% 2.88% 3.23% 1.26% ROE 15.03% 13.86% 11.42% 4.77% 4.74% 14.59% 13.02% 33.88% 33.46% 9.68% ROCE 17.13% 17.64% 13.15% 9.53% 10.36% 20.56% 15.90% 18.16% 24.67% 14.23% Fixed Asset Turnover 6.08 5.86 5.60 3.59 3.14 3.23 2.25 2.33 2.47 1.99 Receivable days 52.11 82.94 106.79 109.11 91.85 62.16 109.23 102.30 71.54 62.01 Inventory Days 170.43 130.61 92.72 160.89 147.66 111.37 77.73 55.39 62.77 56.62 Payable days 85.40 94.41 111.88 189.53 178.44 158.25 217.97 146.17 106.16 100.81 Cash Conversion Cycle 137.13 119.14 87.63 80.47 61.07 15.28 -31.02 11.52 28.15 17.82 Total Debt/Equity 0.88 0.98 0.78 0.92 0.84 0.49 0.45 2.53 3.92 3.06 Interest Cover 2.57 2.89 2.80 1.73 1.56 2.97 2.36 2.19 1.89 1.50

Top Investors:

nikhil kishorchandra vora

arun kumar mukherjee

Annual Reports:

News Update:

Fredun Pharma - Quarterly Results
26th Oct 2024, 21:40 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback